Nachrichten zur Merck KGaA Aktie

Is Recursion Pharmaceuticals Stock a Millionaire Maker?

Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a…

Merck Aktie: Aussichten trüb

Die Merck KGaA verzeichnet in den letzten Handelstagen des Jahres 2024 eine deutliche Abwärtsbewegung an der Frankfurter Börse. Der Pharma-…

Why Viking Therapeutics Tumbled by More Than 10% This Week

News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a…

BMO cuts rating on Merck and Biogen, on lack of near term catalyst By Investing.com

BMO cuts rating on Merck and Biogen, on lack of near term catalyst…

Investing in Merck (NYSE:MRK) three years ago would have delivered you a 43% gain

It hasnt been the best quarter for Merck & Co., Inc. ( NYSE:MRK ) shareholders, since the share price has…

Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks

Collecting dividend income on a recurring basis can help strengthen your financial position and be a way for you to…

Is Moderna Stock a Buy?

Modernas (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The companys revenue, earnings, and stock price…

Where Will Summit Therapeutics Be in 5 Years?

Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab,…

3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly…

MRKs Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals

Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1…

Mercks HIV treatment meets main goal of two late-stage studies By Reuters

Mercks HIV treatment meets main goal of two late-stage studies…

Merck Enters Obesity Space, Buys Rights to Hansohs Oral GLP-1 Drug

Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh Pharma.…

Opening Bell: Dow Jones steigt vor Zinsentscheid; Nvidia, Rigetti, IBM, D-Wave, Merck, Unitedhealth im Fokus

Am US-Aktienmarkt zeichnen sich am Mittwoch zum Handelsstart moderate Gewinne ab. Im Fokus steht die Leitzinsentscheidung zwei Stunden vor Börsenschluss…

Pharmaindustrie: Merck sichert sich Rechte an Abnehmpille in Milliardendeal

Der Pharmakonzern hat eine Lizenzvereinbarung mit dem chinesischem Biotech-Unternehmen Hansoh geschlossen. Merck darf künftig die Abnehmpille der Chinesen vermarkten und…

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion…

Merck pens $2bn deal for obesity drug from China’s Hansoh

Merck & Co Inc (NYSE:MRK, ETR:6MK) has sought a potential weight loss drug candidate through a deal worth up to…

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isnt for the faint of heart. These stocks tend to be highly volatile because of…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

DAX vor Fed-Entscheid leichter – Ceconomy, Commerzbank, Daimler Truck, Infineon, Kontron, Mercedes-Benz, Merck, MTU, Pro7, Redcare im Check

Vor der wichtigen Notenbanksitzung heute Abend halten sich die deutschen Anleger zurück. Der DAX hat den Handel am Dienstag bei…

Mercks BLA for RSV Antibody Clesrovimab Gets FDA Acceptance

The FDA accepts MRKs BLA for clesrovimab, its monoclonal antibody, to protect infants from RSV disease. A decision from the…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der Dax -Konzern…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren…

Merck übernimmt Spezialisten für Zellkulturmodelle

DARMSTADT (dpa-AFX) - Der Darmstädter Pharma- und Technologiekonzern Merck stärkt sein Geschäft mit einer weiteren Übernahme. Der DAX-Konzern kauft das…

Merck: Buy Opportunity Backed By Growth

…

Merck ends development of two antibody programs

…

Merck Has Become Very Cheap Again

…

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

Its been a good year for the stock market as a whole and a tremendous year for a couple of…

Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today

Normally, you might expect to achieve significant gains from stocks if you invest in them for years, perhaps decades. But…

Merck gets positive EU regulatory opinion for Welireg

…

These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

Its been a banner year for the stock market. However, not every stock has been a winner as some sectors…

Prediction: This Stock Will Beat the Market in 2025

It hasnt been a great year for Iovance Biotherapeutics (NASDAQ: IOVA), an innovative mid-cap biotech company. The drugmakers shares have…

MRKs Keytruda & Lynparza Combo Meets Goal in Ovarian Cancer Study

The KEYLYNK-001 study evaluating Mercks Keytruda plus chemotherapy followed by maintenance with Lynparza meets the primary goal in epithelial ovarian…

While This High-Yield Dividend ETF Holds 75 Stocks, Its Top 2 Comprise 16.5% of Its Total Holdings

iShares Core High Dividend ETF (NYSEMKT: HDV) is a popular exchange-traded fund (ETF) among those seeking to generate passive income.…

2 Healthcare Dividend Stocks to Hold for the Long Haul

Investors looking for stocks to hold on to for a while might want to consider dividend-paying companies. Besides offering a…

Why Summit Therapeutics Stock Rocketed 6% Higher on Friday

Summit Therapeutics (NASDAQ: SMMT) stock got a real shot in the arm Friday with the initiation of coverage by a…

Is Now the Time to Buy 3 of the S&P 500s Worst-Performing Stocks of 2024?

The S&P 500 has hit record levels this year and many stocks have generated fantastic returns for investors. But theres…

Merck Aktie: Solide Zahlen, verhaltener Ausblick

Schwarzach am Main (www.aktiencheck.de) - Merck Aktie: Solide Zahlen, verhaltener Ausblick Der Pharma- und Technologiekonzern Merck (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

3 Ultra-Cheap Dividend Stocks to Buy in December

If youre concerned about rising valuations in the stock market or just want some reliable income for your portfolio, now…

Merck-Aktie tiefer: S&P bestätigt Merck KGaAs "A/A-1"-Ratings

Der stabile Rating-Ausblick ist ebenfalls unverändert, wie S&P Global Ratings weiter mitteilte. Der stabile Ausblick spiegele die Annahme wider, dass…

HSBC upgrades Merck stock to Buy on 2025 opportunities By Investing.com

HSBC upgrades Merck stock to Buy on 2025 opportunities…

Mercks ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC

This is the first breakthrough therapy designation granted to MRKs sacituzumab tirumotecan in the United States.…

09:58: Merck: Q3 besser als erwartet, Aktie gibt nach

Bei Merck (DE0006599905) klingeln wieder die Kassen: Der Darmstädter Technologie- und Pharmakonzern konnte das Ergebnis im dritten Quartal unerwartet deutlich…

Merck-Aktie: JP Morgan Chase & Co. gibt Overweight-Bewertung bekannt

Die US-Bank JPMorgan hat Merck KGaA mit einem Kursziel von 190 Euro auf "Overweight" belassen. Das kommende Jahr dürfte für…

Merck Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Merck KGaA mit einem Kursziel von 190 Euro auf "Overweight" belassen.…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Merck KGaA mit einem Kursziel von 190 Euro auf "Overweight" belassen.…

Merck Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Merck KGaA von 205 auf 201 Euro gesenkt,…

DZ Bank senkt fairen Wert für Merck KGaA auf 201 Euro - Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Merck KGaA von 205 auf 201 Euro gesenkt,…

Merck Aktie: Kursziel gesenkt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley stufen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol:…

Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study

MRKs study of PAH drug Winrevair in a more advanced form of the disease shows overwhelming efficacy.…